Found 33 matching trials
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
PHASE3The primary immunogenicity objective is to assess and compare the immunogen...
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
PHASE3The primary objective was to evaluate the persistence of bactericidal antib...
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Understanding the Immune Response to Two Different Meningitis Vaccines
PHASE4The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Location
Oxford Vaccine Group
Treatments Being Tested
MenACWY-CRM conjugate vaccine (Menveo, Novartis)MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)Polysaccharide (subcutaneously)-conjugate Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age
PHASE3Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccha...
Location
FUNCEI, French 3085
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
PHASE3To evaluate the safety and immune response of Novartis MenACWY conjugate va...
Location
Children's Investigational Reserach Program
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine
PHASE3This study compares the safety and immunogenicity profile of combined hepat...
Location
03, Novartis Investigational Site
Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older
N/AA multicenter, single arm, postmarketing surveillance study. This study is ...
Location
Multiple Locations
Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
PHASE2The purpose of this study is to evaluate how well the immuno response again...
Location
Clinical Trials Research Center
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan
PHASE3This study will evaluate the immunogenicity and safety of a single injectio...
Location
Mackay Memorial Hospital,
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults
PHASE3This study will evaluate the lot to lot consistency, safety and immune resp...
Location
Multiple Locations